ResearcherJohns Hopkins UniversityNo recent work listed
Michael Ayars
Matched on ORCID iD 0000-0002-1300-5383; OpenAlex author ID A5052411729. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2015: 1 paper · 2016: 1 paper · 2017: 2 papers
Papers 4
- Susceptibility of ATM-deficient pancreatic cancer cells to radiation. Co-author DOI 10.1080/15384101.2017.1312236↗
- IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic cancer growth. Co-author DOI 10.18632/oncotarget.19848↗
- Overexpression of ankyrin1 promotes pancreatic cancer cell growth. Co-author DOI 10.18632/oncotarget.9009↗
- Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling. Co-author DOI 10.1038/nrgastro.2015.180↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Goggins · 4 shared papers, 2015–2017 · strength 0.34
- Paper Susceptibility of ATM-deficient pancreatic cancer cells to radiation. DOI 10.1080/15384101.2017.1312236↗
- Paper Pancreatic cancer: Classifying pancreatic cancer using gene expression profiling. DOI 10.1038/nrgastro.2015.180↗
- Paper IL2RG, identified as overexpressed by RNA-seq profiling of pancreatic intraepithelial neoplasia, mediates pancreatic ca… DOI 10.18632/oncotarget.19848↗
- James R. Eshleman · 1 shared paper, 2017 · strength 0.12
- Haeryoung Kim · 1 shared paper, 2017 · strength 0.07
- Jun Yu · 1 shared paper, 2017 · strength 0.07
- Koji Shindo · 1 shared paper, 2017 · strength 0.07
- Ralph H. Hruban MD · 1 shared paper, 2017 · strength 0.07
- Noriyuki Omura · 1 shared paper, 2016 · strength 0.05
- Mitsuro Kanda · 1 shared paper, 2016 · strength 0.05
- Masamichi Mizuma · 1 shared paper, 2016 · strength 0.05
- Seung‐Mo Hong · 1 shared paper, 2016 · strength 0.05
- Audrey Vincent · 1 shared paper, 2016 · strength 0.05
- Anirban Maitra · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.